Litcius/Paper detail

Resistance to CDK4/6 inhibition: Mechanisms and strategies to overcome a therapeutic problem in the treatment of hormone receptor-positive metastatic breast cancer

Marios Papadimitriou, Anastasia Pazaiti, Konstantinos Iliakopoulos, Mariam Markouli, Vasiliki Michalaki, Christos Papadimitriou

2022Biochimica et Biophysica Acta (BBA) - Molecular Cell Research59 citationsDOI

Topics & Concepts

PalbociclibCyclin-dependent kinase 6Metastatic breast cancerCyclin-dependent kinase 4MedicinePI3K/AKT/mTOR pathwayOncologyBreast cancerCancerAcquired resistanceInternal medicineCancer researchCyclin-dependent kinaseCell cycleBioinformaticsBiologySignal transductionCyclin-dependent kinase 2BiochemistryAdvanced Breast Cancer TherapiesCancer-related Molecular PathwaysHER2/EGFR in Cancer Research
Resistance to CDK4/6 inhibition: Mechanisms and strategies to overcome a therapeutic problem in the treatment of hormone receptor-positive metastatic breast cancer | Litcius